These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28291758)
1. Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis. Cole JC; Giangreco I; Groom CR Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):234-239. PubMed ID: 28291758 [TBL] [Abstract][Full Text] [Related]
2. The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery. Groom CR; Cole JC Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):240-245. PubMed ID: 28291759 [TBL] [Abstract][Full Text] [Related]
3. Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals. Spackman PR; Yu LJ; Morton CJ; Parker MW; Bond CS; Spackman MA; Jayatilaka D; Thomas SP Angew Chem Int Ed Engl; 2019 Nov; 58(47):16780-16784. PubMed ID: 31385643 [TBL] [Abstract][Full Text] [Related]
4. Validating and understanding ring conformations using small molecule crystallographic data. Cottrell SJ; Olsson TS; Taylor R; Cole JC; Liebeschuetz JW J Chem Inf Model; 2012 Apr; 52(4):956-62. PubMed ID: 22372622 [TBL] [Abstract][Full Text] [Related]
5. Improved ligand geometries in crystallographic refinement using AFITT in PHENIX. Janowski PA; Moriarty NW; Kelley BP; Case DA; York DM; Adams PD; Warren GL Acta Crystallogr D Struct Biol; 2016 Sep; 72(Pt 9):1062-72. PubMed ID: 27599738 [TBL] [Abstract][Full Text] [Related]
6. Ligand fitting with CCP4. Nicholls RA Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):158-170. PubMed ID: 28177312 [TBL] [Abstract][Full Text] [Related]
7. Validation and extraction of molecular-geometry information from small-molecule databases. Long F; Nicholls RA; Emsley P; Graǽulis S; Merkys A; Vaitkus A; Murshudov GN Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):103-111. PubMed ID: 28177306 [TBL] [Abstract][Full Text] [Related]
8. Tools for ligand validation in Coot. Emsley P Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):203-210. PubMed ID: 28291755 [TBL] [Abstract][Full Text] [Related]
9. The critical role of QM/MM X-ray refinement and accurate tautomer/protomer determination in structure-based drug design. Borbulevych OY; Martin RI; Westerhoff LM J Comput Aided Mol Des; 2021 Apr; 35(4):433-451. PubMed ID: 33108589 [TBL] [Abstract][Full Text] [Related]
10. PURY: a database of geometric restraints of hetero compounds for refinement in complexes with macromolecular structures. Andrejasic M; Praaenikar J; Turk D Acta Crystallogr D Biol Crystallogr; 2008 Nov; 64(Pt 11):1093-109. PubMed ID: 19020347 [TBL] [Abstract][Full Text] [Related]
11. The CSD Drug Subset: The Changing Chemistry and Crystallography of Small Molecule Pharmaceuticals. Bryant MJ; Black SN; Blade H; Docherty R; Maloney AGP; Taylor SC J Pharm Sci; 2019 May; 108(5):1655-1662. PubMed ID: 30615878 [TBL] [Abstract][Full Text] [Related]
12. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Schüttelkopf AW; van Aalten DM Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1355-63. PubMed ID: 15272157 [TBL] [Abstract][Full Text] [Related]
13. Validation of Protein-Ligand Crystal Structure Models: Small Molecule and Peptide Ligands. Pozharski E; Deller MC; Rupp B Methods Mol Biol; 2017; 1607():611-625. PubMed ID: 28573591 [TBL] [Abstract][Full Text] [Related]
14. Twilight reloaded: the peptide experience. Weichenberger CX; Pozharski E; Rupp B Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):211-222. PubMed ID: 28291756 [TBL] [Abstract][Full Text] [Related]
15. High-throughput quantum-mechanics/molecular-mechanics (ONIOM) macromolecular crystallographic refinement with PHENIX/DivCon: the impact of mixed Hamiltonian methods on ligand and protein structure. Borbulevych O; Martin RI; Westerhoff LM Acta Crystallogr D Struct Biol; 2018 Nov; 74(Pt 11):1063-1077. PubMed ID: 30387765 [TBL] [Abstract][Full Text] [Related]
16. Small-molecule 3D structure prediction using open crystallography data. Sadowski P; Baldi P J Chem Inf Model; 2013 Dec; 53(12):3127-30. PubMed ID: 24261562 [TBL] [Abstract][Full Text] [Related]
17. Estimation of the protein-ligand interaction energy for model building and validation. Beshnova DA; Pereira J; Lamzin VS Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):195-202. PubMed ID: 28291754 [TBL] [Abstract][Full Text] [Related]
18. Keep it together: restraints in crystallographic refinement of macromolecule-ligand complexes. Steiner RA; Tucker JA Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):93-102. PubMed ID: 28177305 [TBL] [Abstract][Full Text] [Related]
19. Conformation-dependent restraints for polynucleotides: the sugar moiety. Kowiel M; Brzezinski D; Gilski M; Jaskolski M Nucleic Acids Res; 2020 Jan; 48(2):962-973. PubMed ID: 31799624 [TBL] [Abstract][Full Text] [Related]
20. AceDRG: a stereochemical description generator for ligands. Long F; Nicholls RA; Emsley P; Graǽulis S; Merkys A; Vaitkus A; Murshudov GN Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):112-122. PubMed ID: 28177307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]